GlycoMimetics CEO chosen as new BIO chairwoman

04/24/2013 | American City Business Journals

GlycoMimetics President and CEO Rachel King has been elected as the 2013-2014 chairwoman of BIO, succeeding former Human Genome Sciences CEO Tom Watkins. King has been a part of national policy discussions with BIO and was among the group's representatives at a 2011 meeting on the approval process with FDA Commissioner Dr. Margaret Hamburg.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC